Skip to main content
Log in

Clinical Experience with Implantable Atrial and Combined Atrioventricular Defibrillators

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

The high prevalence of atrial fibrillation (AF) and its clinical complications, the poor efficacy of medical therapy for preventing recurrences, and dissatisfaction with alternative modes of therapy stimulated interest in implantable atrial and combined atrioventricular defibrillators.

In a multicenter study, the safety and efficacy of a stand alone implantable atrial defibrillator, the Metrix system, were evaluated. The device was implanted in 51 patients with highly symptomatic episodes of AF refractory to pharmacological treatment. During a follow-up of 9 months, 96% of 227 spontaneous AF episodes were successfully converted to sinus rhythm in 41 patients. In 62 episodes (27%), several shocks and/or additional drug treatment were required to maintain stable sinus rhythm because of early recurrences of AF. A total of 3719 shocks were delivered and no induction of ventricular proarrhythmia or inaccurately synchronized shocks occurred. The AF detection algorithm exhibited a 100% specificity for the recognition of sinus rhythm and a 92.3% sensitivity for the detection of AF.

The combined atrioventricular defibrillator, Jewel AF 7250, was evaluated in a multicenter, randomized, cross-over trial. The primary study objectives included: overall safety as determined by complications-free survival at 6 months, efficacy of tiered atrial pacing and defibrillation therapies for termination of spontaneous atrial tachycardias (AT) and AF, and relative sensitivity of a new dual-chamber detection algorithm. The device was implanted in 211 patients with either a history of ventricular tachyarrhythmias (VT/VF) alone or with a history of both AT/AF and VT/VF. During a mean follow-up of 4.5 months, it has been shown that the Jewel AF is safe and effective in treating atrial and ventricular tachyarrhythmias. Pace termination of 85% of AT episodes were achieved with painless delivery of antitachycardia pacing; additional 35% of AT episodes were terminated by high frequency burst pacing.

Conclusions: The stand alone implantable atrial defibrillator may be safe and clinically useful in selected patients for the treatment of highly symptomatic, drug resistant recurrences of AF. The combined atrioventricular defibrillator may be particularly indicated in patients presenting with both a history of atrial and ventricular tachyarrhythmias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983–988.

    Google Scholar 

  2. Bialy D, Lehmann MH, Schumacher DN, et al. Hospitalization for arrhythmias in the United States: Importance of atrial fibrillation. J Am Coll Cardiol 1992;19:41A (Abstract).

    Google Scholar 

  3. Kannel WB, Abbott RB, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982;306:1018–1022.

    Google Scholar 

  4. Hillsey RE, Wharton JM. Implantable atrial defibrillators. J Cardiovasc Electrophysiol 1995;6:634–648.

    Google Scholar 

  5. Lüderitz B, Pfeiffer D, Tebbenjohanns J, et al. Nonpharmacologic strategies for treating atrial fibrillation. Am J Cardiol 1966;77:45A-52A.

    Google Scholar 

  6. Jung W, Lüderitz B. Implantable atrial defibrillator. Which results and indications? In: Raviele A, ed. Cardiac Arrhythmias. Heidelberg: Springer Verlag, 1997:100–109.

    Google Scholar 

  7. Jung W, Wolpert C, Esmailzadeh B, et al. Specific considerations with the automatic implantable atrial defibrillator. J Cardiovasc Electrophysiol 1998;9:S193-S201.

    Google Scholar 

  8. Jung W, Lüderitz B. Implantable atrial defibrillator: Quo vadis? PACE 1997;20:2141–2145 (Editorial).

    Google Scholar 

  9. Jung W, Wolpert C, Herwig S, et al. Initial experience with the implantable atrial defibrillator. G Ital Cardiol 1998;28(Suppl 1):592–594.

    Google Scholar 

  10. Jung W, Lüderitz B. Implantable atrial defibrillator. Herzschr Elektrophys 1998;23:251–259.

    Google Scholar 

  11. Jung W, Wolpert C, Spehl S, et al. Initial clinical experience with the implantable atrial and combined atrioventricular defibrillator. Herzschr Elektrophys 1998;9:94–101.

    Google Scholar 

  12. Lüderitz B, Jung W. Quality of life of patients with atrial fibrillation. In: Santini M, ed. Progress in Clinical Pacing Armonk, NY: Futura Media Sevices Inc., 1996:253–262.

    Google Scholar 

  13. Jung W, Lüderitz B. Quality of life in atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:S177-S186.

    Google Scholar 

  14. Sra JS, Maglio C, Dhala A, et al. Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation. J Am Coll Cardiol 1996;28:1532–1538.

    Google Scholar 

  15. Lau CP, Tse HF, Lok NS, et al. Initial clinical experience with an implantable human atrial defibrillator. PACE 1977;20:220–225.

    Google Scholar 

  16. Wellens HJJ, Lau CP, Lüderitz B, et al., for the Metrix Investigators. The atrioverter, an implantable device for treatment of atrial fibrillation. Circulation 1998;98:1651–1656.

    Google Scholar 

  17. Jung W, Wolpert C, Spehl S et al., for the Worldwide Metrix Investigators. Worldwide experience with the Metrix implantable atrial defibrillator. In: Adornato E, ed. Rhythm Control from Cardiac Evaluation to Treatment. Roma: Ediziono Luigi Pozzi, 1998:139–143.

    Google Scholar 

  18. Jung W, Wolpert C, Spehl S, et al. Implantable atrial defibrillator with ventricular back-up. G Ital Cardiol 1998;28(Suppl 1):581–583.

    Google Scholar 

  19. Jung W, Lüderitz B. Implantation of a new arrhythmia management system in patients with supraventricular and ventricular tachyarrhythmias. Lancet 1997;349:853–854.

    Google Scholar 

  20. Jung W, Spehl S, Wolpert C, et al. Initial experience with a new dual-chamber defibrillator in humans. Circulation 1997;96:208 (Abstract).

    Google Scholar 

  21. Jung W, Brachmann J, Den Dulk K, et al. Initial clinical experience with a new arrhythmia management device. Circulation 1997;96:208 (Abstract).

    Google Scholar 

  22. Wharton M, Santini M, for the Worldwide Jewel AF Investigators. Treatment of spontaneous atrial tachyarrhythmias with the Medtronic 7250 Jewel AF: Worldwide clinical experience. Circulation 1998;98:I-190.

    Google Scholar 

  23. Jung W, Wolpert C, Tenzer D, et al. Incidence of spontaneous atrial tachyarrhythmias in patients treated with a combined atrioventricular defibrillator. Circulation 1998;98:I-190.

    Google Scholar 

  24. Reuter D, Kriplen MM, Ayers GM. Mechanisms of atrial fibrillation early recurrences and potential electrophysiological modifications. In: Santini M, ed. Progress in Clinical Pacing. Armonk, NY: Futura Media Services, Inc., 1998:25–36.

    Google Scholar 

  25. Gallagher MM, Camm AJ. Classification of atrial fibrillation. PACE 1997;20:1603–1605.

    Google Scholar 

  26. Griffin JC, Ayers GM, Adams J, et al. Is the automatic atrial defibrillator a promising approach? J Cardiovasc Electrophysiol 1996;7:1217–1224.

    Google Scholar 

  27. Daubert C, Mabo P, Berder V. Arrhythmia prevention by permanent atrial resynchronization in advanced interatrial block. Eur Heart J 1990:11:237–242.

    Google Scholar 

  28. Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996;28:687–694.

    Google Scholar 

  29. Prakash A, Saksena S, Hill M, et al. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J Am Coll Cardiol 1997:29:1007–1014.

    Google Scholar 

  30. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659–666.

    Google Scholar 

  31. Lau CP, Tse HF, Ayers GM. Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. J Am Coll Cardiol 1999;33:1217–1226.

    Google Scholar 

  32. Schumacher B, Jung W, Lewalter T, et al. Radiofrquency ablation of atrial _utter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 1999;83:710–713.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, W., Wolpert, C., Esmailzadeh, B. et al. Clinical Experience with Implantable Atrial and Combined Atrioventricular Defibrillators. J Interv Card Electrophysiol 4 (Suppl 1), 185–195 (2000). https://doi.org/10.1023/A:1009819707643

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009819707643

Navigation